Your Location：
Home >
Browse articles >
A Randomized，Double-blind，Multi-center Clinical Trial of Tengfu Jiangya Tablets Combined with Valsartan/Amlodipine in Treatment of Grade 2 Hypertension with Hyperactivity of Liver Yang
Updated：2024-04-16
Previous|Next

    • A Randomized，Double-blind，Multi-center Clinical Trial of Tengfu Jiangya Tablets Combined with Valsartan/Amlodipine in Treatment of Grade 2 Hypertension with Hyperactivity of Liver Yang

      Enhanced Publication
    • QI Yuchen , LI Yunlun , WU Yujie , WANG Haiquan , WANG Yu
    • Chinese Journal of Experimental Traditional Medical Formulae Vol. 30, Issue 9, Pages: 83-92(2024)

    • DOI： 10.13422/j.cnki.syfjx.20241196     

      CLC：

    Scan QR Code

  •  
  •  

  • AI Introduction

  • Full Text(HTML)

  • Figs( 0 ) Tabs( 12 )

  • References

  • Publication Info

  • Metrics

209

Views

143

Downloads

0

CSCD

Alert me when the article has been cited
Submit
Tools
  • BibTeXDownload
  • EndnoteDownload
  • RefMan Download
  • NoteExpressDownload
  • NoteFirstDownload

Related Articles

Traditional Chinese Medicine Treatment of Colorectal Cancer Based on AMPK Signaling Pathway： A Review
Astragali Radix Polysaccharides Promote M2 Polarization of OGD/R-induced BV2 Microglia by Inhibiting TLR4/NF-κB Signaling Pathway
Effect and Mechanism of Liangyi Paste on Hepatic Lipid Deposition in Naturally Aged Mice with High-fat Diet via Cuproptosis/Oxidative Stress Pathway
Expert Consensus on Clinical Application of SkinPro Ointment
Key Issues and Research Ideas of Traditional Chinese Medicine Anti-aging Guided by Essence-Qi-spirit Theory of Qiluo Doctrine

Related Author

QI Yuchen
LI Yunlun
WU Yujie
WANG Haiquan
WANG Yu

Related Institution

Shandong University of Traditional Chinese Medicine
Affiliated Hospital of Shandong University of Traditional Chinese Medicine